Aim: We aimed to delineate the effects of immunoglobulin (Ig)M-mediated autoimmune responses directed against malondialdehyde (MDA) and nitroso (SNO) adducts on nitro-oxidative stress and depressive and physiosomatic symptoms (DPSS) at the end of term.
Aim: We aimed to delineate the effects of immunoglobulin (Ig)M-mediated autoimmune responses directed against malondialdehyde (MDA) and nitroso (SNO) adducts on nitro-oxidative stress and depressive and physiosomatic symptoms (DPSS) at the end of term.
Methods: IgM responses to MDA, NO (nitroso) adducts formed by nitrosylation, and NO 2 tyrosine formed by nitration were measured as well as hydroperoxides (ferrous oxidation xylenol orange), advanced protein oxidation products (AOPP), and NO metabolite (NOx) levels in women at the end of term pregnancy and in normal controls.
Results: IgM responses to MDA were significantly and inversely associated with AOPP, ferrous oxidation xylenol orange, and NOx and DPSS. IgM responses to NO adducts were significantly and inversely associated with DPSS and positively with NOx levels. There were significant associations between IgM responses to MDA, NO adducts, and NO 2 tyrosine. The DPSS score was predicted by AOPP and a lifetime history of premenstrual syndrome (both positively) and IgM responses to NO adducts (inversely). Furthermore, 71.8% of the variance in the index of nitro-oxidative stress was explained by lowered IgM responses to MDA, antioxidant levels (zinc, total radical trapping parameter), and inflammatory mediators.
Conclusion:
Lowered levels of IgM responses to MDA during pregnancy are accompanied by a reduced regulation of nitro-oxidative processes thereby explaining increased oxidative and nitrosative stress biomarkers in association with DPSS. IgM responses to NO adducts, which reflect nitrosylation as a consequence of increased NO production, regulate DPSS symptoms at the end of term and are a trait marker of major depression. IgM responses to MDA are a key part of the compensatory anti-inflammatory responses system. the production of secondary byproducts, including malondialdehyde (MDA).
1,2 MDA, in turn, may cause deleterious effects to proteins and DNA thereby exerting neurotoxic effects and promoting cell death. 3, 4 Increased MDA levels in depression and bipolar disorder are now well established [5] [6] [7] [8] [9] and have been consolidated in meta-analyses. [10] [11] [12] MDA is an oxidative-specific epitope (OSE) that is expressed on the cell surface of oxidized low-density lipoprotein (LDL), apoptotic and dying cells, 13 and circulating microparticles (MP).
14 Once expressed, MDA may be recognized by immune cells 15 thereby triggering natural IgM-mediated autoimmune responses directed against MDA. 16 Moreover, elevated levels of IgM antibodies bind to MDAmodified LDL on the surface of circulating MP. 14 Immunoglobulin (Ig)M-mediated responses to MDA have immune-regulatory functions 13 and clear inflammatory debris and dying and apoptotic cells, thereby regulating inflammatory responses. 13, 15, 17 IgM antibodies directed against MDA exert protective effects by inhibiting MP-activated production of monocytic interleukin (IL)-8. 14 As such, natural IgM-mediated autoimmune responses are part of the compensatory anti-inflammatory reflex system, which is activated in depression and bipolar disorder thereby downregulating an overzealous inflammatory response. 18 Mood disorders are accompanied by different negative immunoregulatory processes that accompany the primary immune response, including: increased synthesis of the IL-1 receptor antagonist (IL-1RA), which inhibits IL-1 signaling; 18 increased secretion of transforming growth factor-β, an anti-proliferative cytokine; 19 increased glucocorticoid and IL-10 production; increased IL-2R levels, which induce a state of IL-2 starvation; and increased production of some acute phase proteins that have immunosuppressive properties (e.g. haptoglobin) and lowered plasma tryptophan levels. 18 In pregnancy, IgM responses to OSE, including MDA, are lowered at the end of term, 20 and therefore lowered regulatory effects may be present. Increased levels of oxidative and nitrosative stress (O&NS), especially increased protein oxidation (as measured with advanced oxidation protein products) and nitric oxide (NO) production (as measured with NO metabolites) are strongly associated with prenatal depressive and physiosomatic symptoms (DPSS; including fatigue, pain, dyspepsia, and gastrointestinal symptoms).
20,21
Therefore, we may hypothesize that lowered IgMresponses to MDA could play a role in the increased O&NS responses and DPSS. However, there are no data available on possible associations between IgM responses to MDA and increased O&NS and DPSS at the end of term. Depression is accompanied by increased NO production as a result of increased production of inducible nitric oxide synthase (iNOS). 22, 23 As a consequence, proteins may be nitrosylated by the incorporation of a nitric oxide into nitroso (SNO). 24 Nitrosylation, when occurring in optimum or physiologic levels, has regulatory activities, including a DNA-repairing mechanism, regulation of cellular processes, mediating synaptic plasticity, and neuronal survival, [24] [25] [26] whilst excessive nitrosylation (hypernitrosylation) has detrimental effects, including neurotoxic effects, mitochondrial dysfunctions, synaptic loss, and neuronal death, ultimately leading to neurodegenerative processes. 24, 25, 27, 28 Moreover, when NO (nitroso) binds to proteins, neoantigens are formed and some of these are immunogenic thereby triggering IgM responses to NO adducts. 29 Major depression is accompanied by increased IgM responses to nitroso (NO) adducts. 16, 20, 30 Another consequence of elevated iNOS and NO production is peroxynitrite formation, which may lead to increased nitration of proteins, and NO 2 tyrosine formation. 31 NO 2 tyrosine levels are increased in depression and bipolar disorder. 12, [32] [33] [34] Moreover, NO 2 tyrosine is immunogenic and may trigger IgM responses directed against NO 2 tyrosine. 35, 36 However, there are no data on possible correlations between increased NO production and IgM responses to NO adducts or NO 2 tyrosine.
This study aimed to: (i) examine the associations between IgM directed to MDA and NO adducts and O&NS biomarkers and prenatal DPSS; and (ii) examine the associations between NO metabolites (NOx) production and IgM responses to NO adducts and NO 2 tyrosine at the end of term pregnancy.
Thailand, and 23 non-pregnant healthy women. Inclusion criteria for pregnant women were: (i) having planned to give birth and attend postpartum follow ups at King Chulalongkorn Memorial Hospital; (ii) at least 18 years of age; and (iii) being able to read and write Thai language. Exclusion criteria for pregnant women were: (i) axis I disorder(s) (except bipolar disorder and major depressive disorder) detected by the Mini International Neuropsy- 
Measures Clinical assessments
Pregnant women at the end of term were evaluated by a senior gynecologist and a senior psychiatrist. All 73 participants were assessed by using self-rating questionnaires or interviews, including the Edinburgh Postnatal Depression Scale (EPDS)-Thai version, 38, 39 the Beck Depression Inventory (BDI), 40 ,41 the 17-item Hamilton Depression Rating Scale (HAMD), 42 and a structured interview using the M.I.N.I.-Thai version. 37 The senior psychiatrist also assessed premenstrual syndrome (PMS), which is a recurrent pattern of physiosomatic symptoms (PS; body aches, tender breasts, fatigue, bloating) and mood symptoms (depression and anxiety symptoms, tension and irritability, decreased concentration), appearing after ovulation in the luteal phase and resolving with onset of menstruation. As explained previously, 43 we computed a severity PS score. Thus, we assessed persistent fatigue (present, not present) and PS (i.e., myalgia, back pain, dyspepsia and constipation) in the third trimester and computed the first principal component (PC) by factor analysis subtracted from the five PS (PC PS). There was only one factor with an eigenvalue > 1.0 explaining 48.4% of the variance and loading highly on fatigue (0.518), muscle ache (0.852), back pain (0.802), dyspepsia (0.526), and constipation (0.712).
Pregnant women with an EPDS score ≥ 11 were categorized as being depressed. 38, 39 All participants were asked to complete a questionnaire to obtain sociodemographic, medical, and obstetric information. We also measured height (in m) with a manual height measure instrument and bodyweight (in kg) with a digital weighing scale. Body mass index (BMI) was calculated using the formula: BMI = body weight (kg) / height (m) 2 .
Assays
In pregnant and non-pregnant women, fasting blood was sampled at 08.00 hours for the assay of IgM-mediated autoimmune responses directed against MDA, NO adducts, and NO 2 tyrosine. We also measured immuno-inflammatory markers, namely C-reactive protein (CRP) and haptoglobin (Hp), antioxidants (namely zinc and total radical trapping antioxidant parameter [TRAP]), and O&NS biomarkers (namely advanced oxidation protein products [AOPP] , hydroperoxides [ferrous oxidation xylenol orange (FOX)], and NOx).
We employed an enzyme-linked immunosorbent assay to measure IgM levels directed against conjugated MDA. 29, 44, 45 Then, 5.280 mL MDA was mixed with 720 μL 4N HCL in 20 mL water. After 10 min stirring at 37 C, this solution was mixed in 20 mL of water containing 200 μL of bovine serum albumin (BSA). The pH was adjusted at 7 during 2 h at 37 C. Then, the mixture was purified by dialysis with stirring water. Polystyrene 96-well plates (NUNC) were coated with 200 μL solution containing the conjugate at 80 μg/mL in 0.05 M carbonate buffer at pH 9.6. Well plates were incubated at 4 C for 16 h under agitation. Then, a 200-μL blocking solution (phosphate-buffered saline [PBS], 2.5 g/L BSA) was added for 1 h and placed at 37 C. Following three washes with PBS, plates were filled with 100 μL of sera diluted at 1:1000 in the blocking buffer A (PBS, 2 g/L BSA) and incubated at 37 C for 1 h 45 min. After three washes with PBS-0.05% Tween 20, plates were incubated at 37
C for 1 h with peroxidase-labeled anti-human IgM secondary antibodies diluted respectively at 1:15 000, in the blocking buffer (PBS, 2 g/L BSA). They were then washed three times with PBS 0.05% Tween 20, and incubated with the detection solution for 10 min in the dark. Chromogen detection solution was used for the peroxidase assay at 8% in 0.1 M acetate and 0.01 M phosphate buffer (pH 5.0) containing 0.01% H 2 O 2 . The reaction was stopped with 25 μL 2-N HCl. Optical densities were measured at 492 nm using a multiscan spectrophotometer. All assays were carried out in duplicate.
In order to mimic nitrosylation processes, NO tryptophan (NOW), NO arginine, and NO cysteinyl were synthesized by linking haptens to BSA (SigmaAldrich, St. Louis, MO, USA) using glutaraldehyde (G). 29, 44, 45 The synthesis of these conjugates has been described previously. 46 Each hapten conjugate was nitrosylated using sodium nitrite (NaNO 2 ) dissolved in 2 mL of each conjugate, in 0.5 M HCl at 37 C for 2 h, while shaking in the dark. Conjugates were then dialyzed at 4 C for 24 h against a PBS (10 −2 M NaH 2 PO 4 , 12 H 2 O; 0.15 M NaCl; pH 7.4) solution. S-nitrosothiol bond formation was determined by spectrophotometry. The S-nitrosothiol compounds possess two absorbance maxima, at 336 and 550 nm, respectively: e 336 nm = 900 M The assays for the titers of IgM have been extensively described elsewhere. 29, 47 Briefly, polystyrene 96-well plates (NUNC) were coated with 200 μL solution containing the NO and NO 2 conjugates at 10 μg/mL in 0.05 M carbonate buffer at pH 9.6. Well plates were incubated at 4 C for 16 h under agitation. Then, 200 μL of blocking solution (PBS, 2.5 g/L BSA) was added for 1 h and placed at 37 C. Following three washes with PBS, plates were filled with 100 μL of sera diluted at 1:1000 in the blocking buffer A (PBS, 0.05% Tween 20, 10% Glycerol, 2.5 g/L BSA, 1 g/L BSA-G) and incubated at 37 C for 2 h. After three washes with PBS-0.05% Tween 20, plates were incubated at 37
C for 1 h with peroxidase-labeled anti-human IgM secondary antibodies diluted respectively at 1:15 000 in the blocking buffer (PBS, 0.05% Tween 20, 2.5 g/L BSA). They were then washed three times with PBS-0.05% Tween 20, and incubated with the detection solution for 10 min in the dark. Chromogen detection solution was used for the peroxidase assay at 8% in 0.1 M acetate and 0.01 M phosphate buffer (pH 5.0) containing 0.01% H 2 O 2 . The reaction was stopped with 25 μL 2-N HCl. Optical densities were measured at 492 nm using a multiscan spectrophotometer. All assays were carried out in duplicate. The intra-assay coefficients of variation (CV) were <6%.
We measured hs-CRP using the high-sensitivity CRP Vario assay (Abbott Laboratories, Abbott Park, IL, USA) on Architect cSystems. Intra-assay CV values were <4.0%. Serum zinc levels were measured using an atomic absorption spectrometric method (PinAAcle / Perkin Elmer Life Sciences, Zaventem, Belgium). The VITROS Chemistry Products HPT Reagent was used on the VITROS 5.1 FS Chemistry System to assay haptoglobin (spectrophotometric method). TRAP was evaluated according to the method described by Repetto et al. 48 in microplate reader Victor X-3, Perkin Elmer (Waltham, MA, USA). Experimental conditions were: running time of 25 min, response range from 300 to 620 nm, and a temperature of 30 C. This method detects hydro and/or liposoluble antioxidants present in serum. The results were expressed in μM trolox. Plasma AOPP levels were quantified using the method described by Hanasand et al. 49 in a microplate reader, Perkin Elmer, model EnSpire (Waltham, MA, USA) at a wavelength of 340 nm. AOPP concentration was expressed in μM of equivalent chloramine levels were assessed indirectly by determining the plasma nitrite concentration using an adaptation of the technique described Navarro-Gonzálvez et al. 50 This method is based on the reduction of the nitrate present in the sample to nitrite by oxidation-reduction reactions mediated by the system cadmium-copper reagent. Thereafter, Griess reagent was added to induce diazotization, forming a colored complex and subsequent detection at 540 nm. The quantification of NOx was made in a microplate reader Asys Expert Plus, Biochrom (Holliston, MA, USA). The nitric oxide concentration was expressed in μM. Hydroperoxides were determined using the FOX. The reading was performed at 560 nm in a spectrophotometer Helios α, Thermo Spectronic (Waltham, MA, USA). The concentration was expressed in mM.
Statistical analysis
We used analyses of contingency tables (X 2 -test) to assess associations between nominal variables, and analyses of variance to check differences in scale variables between groups. Correlation matrices using Pearson's product moment, Spearman's rank order, and point-biserial correlation were employed to check univariate associations among variables. Multivariate general linear model (GLM) analysis was used to assess the effects of independent (predictor) variables (including diagnosis and IgMmediated responses to MDA) on dependent variables (e.g., O&NS biomarkers). Tests for betweensubjects effects were consequently used to assess the univariate effects of significant predictor variables on each of the dependent variables. Univariate GLM analysis was used to check the effects of independent variables (e.g., diagnosis, age, IgM-mediated responses) on one dependent variable (e.g., nitrooxidative index). Automatic stepwise multiple regression analyses were carried out to assess the most significant predictors (e.g., diagnosis, O&NS biomarkers, IgM responses) of dependent variables. We also used automatic stepwise binary regression analyses to assess the most significant predictors of a dichotomy. We computed odds ratios (OR) and 95% confidence intervals (CI). Ln transformations were used to normalize the data distribution (assessed using the Kolmogorov-Smirnov test), including CRP, AOPP, and NOx. Z-values of all biomarker data were computed and consequently we computed z-unit weighted composite scores, namely: (i) zIgM directed to NOW + zIgM directed to NO-Arg + zIgM directed to NO-cysteinyl (zIgM-NO: index of nitrosylation); (ii) zNOx + zIgM-NO + zIgM to NO 2 tyrosine (zNOx + NO + NO 2 : index of total NO turnover); (iii) zAOPP + zNOx (index of nitro-oxidative damage to proteins); and (iv) zAOPP + zNOx + zFOX (overall index of nitrooxidative damage). There were highly significant (all P < 0.001) intercorrelations between end-of-term BDI, EPDS, HAMD, and PS scores and therefore we have combined those symptoms into one z-unit composite score (zDPSS: index of depressive and physiosomatic symptomatology at the end of term) computed as z-scores of the HAMD values (zHAMD) + zEPDS + z BDI + zPC PS. All results of regression analyses were always checked for multicollinearity. Statistical analyses were performed using IBM SPSS for Windows version 22. Tests were 2-tailed and a P-value of 0.05 was used for statistical significance. Table 1 shows the sociodemographic, clinical, and biomarker data of subjects divided into those with higher versus lower (median split) DPSS scores. There were no significant differences in age, IgM directed against NO adducts and NO 2 tyrosine, haptoglobin, or zNOx + NO + NO 2 between the two groups. Subjects with increased DPSS scores showed higher BMI, lifetime histories of PMS, depression, post-partum depression, anxiety disorders, alcohol use, CRP, AOPP, FOX, NOx, zAOPP + NOx, and zAOPP + FOX + NOx than those with a lower score. Serum zinc and TRAP were significantly associated with lower DPSS scores. Nevertheless, we stress that no P corrections were employed to interpret these univariate results as they were used together with the correlation matrices among the variables to delineate the independent variables that we subsequently employed as independent predictors in multivariate GLM and binary logistic regression analyses. Table 2 shows the results of a multivariate GLM analysis with five O&NS biomarkers (AOPP, FOX, NOx, zAOPP + NOx, and zAOPP + FOX + NOx) and zDPSS as dependent variables, and IgM responses to MDA and NO adducts as primary outcome variables, while adjusting for the effect of inflammation (CRP and haptoglobin), antioxidant levels (zinc and TRAP), and diagnoses (lifetime histories of depression, PMS, and post-partum depression). We found that these explanatory variables highly significantly predicted the O&NS biomarkers and DPSS score. The most significant predictors were (in descending order): zinc (38.2% of the variance), IgM responses to NO (36.2% of the variance), and IgM responses to MDA (28.8% of the variance). The effects of diagnoses and CRP and TRAP were less significant, while haptoglobin and a history of postpartum depression were not significant. Table 3 (regressions #1) shows the results of automatic stepwise regression analyses with AOPP, FOX, NOx, zAOPP + NOx, and zAOPP + FOX + NOx and zDPSS as dependent variables. Regression #1 shows that AOPP levels were strongly (56.8% of the variance) predicted by CRP, and IgM responses to NO adducts (all positively) and zinc, TRAP and IgM responses to MDA (inversely). Figure 1 shows the significant inverse correlation between AOPP levels and IgM responses directed to MDA. Regression #2 and #3 show that 60.7% and 59.4% of the variance in FOX and NOx, respectively, was explained by CRP and IgM responses to NO adducts (positively) and zinc, TRAP, IgM responses to MDA, and haptoglobin (all negatively). FOX levels were significantly higher in pregnant women (mean 8SD = 2.44 AE 0.75 nM) than in non-pregnant women (1.27 AE 0.57 nM; F = 45.63, d.f. = 1/71, P < 0.001). Regression #4 shows that the same variables explained 72.8% and 71.8% of the variances in zAOPP + NOx and zAOPP + FOX + NOx, respectively.
RESULTS

Descriptive statistics
Prediction of O&NS biomarkers
Prediction of the DPSS score
Regression #6 (Table 3) shows that a large part of the variance (57.4%) in DPSS score is explained by the regression on lifetime histories of mood disorders and PMS, CRP (all positively), and zinc and IgM responses to MDA (both negatively). After removal of serum zinc of the predictor list, we found that the DPSS score was best predicted by AOPP and family histories of mood disorders and PMS (all positively) and IgM responses to NO adducts (negatively; see regression #7). Bivariate regression analyses showed that the EDSS score was significantly associated with AOPP (r = 0.476, P < 0.001), FOX (r = 0.415, P < 0.001), and NOx (r = 0.413, P < 0.001, all n = 72). Table 4 shows the results of an automatic stepwise regression analysis with the study group with increased DPSS scores as dependent variable (and the group with lower DPSS values as reference group) and with the same explanatory variables as described in Table 3 . A higher DPSS score was significantly predicted (X 2 = 37.08, d.f. = 3, P < 0.001, Nagelkerke = 0.537) by increased AOPP, a history of PMS, and lowered IgM responses to NO adducts. Overall, 80.6% of the cases were correctly classified with a sensitivity of 80.6% and specificity of 80.6%.
Prediction of the overall NO turnover composite score zNOx + NO + NO 2 Table 5 shows the results of automatic stepwise regression analyses with the composite score zNOx + NO + NO 2 and zNOx, zIgM-NO and zIgM-NO 2 tyrosine as dependent variables and the same predictors as listed in Table 3 together with a history of alcohol use, pregnancy, TRAP, and zinc as explanatory variables. We found that 31.5% of the variance in the composite score was explained by five predictor variables, namely a history of mood disorders and IgM responses to MDA (both positively) and prenatal depression, a history of alcohol use, and age (all three inversely). Forced entry of pregnancy did not change these results and showed that pregnancy was not significant (t = 0.72, P = 0.476). Consequently, we performed automatic stepwise regression analyses with zNOx, zIgM-NO, and zIgM-NO 2 tyrosine as dependent variables, while entering the same explanatory variables as listed above. We found that 46.8% of the variance in NOx is significantly predicted by pregnancy and a lifetime history of mood disorders (both positively) and alcohol use (negatively). After entering zinc and TRAP (both inversely associated with NOx) the effects of pregnancy were no longer significant (t = 1.64, P = 0.11). We found that 9.1% of the variance in IgM responses to NO adducts was explained by a history of mood disorders (positively) and prenatal depression (inversely). Forced entry of pregnancy showed that pregnancy had no significant effect (t = −0.27, P = 0.792). We detected that 23.2% of the variance in IgM responses to NO 2 tyrosine was explained by age (inversely) and IgM responses to MDA (positively).
Are NOx levels predicting nitrosylation and/or nitration? Table 6 shows the outcome of a multivariate GLM analysis with IgM responses to NO adducts and NO 2 tyrosine as dependent variables and NOx together with IgM responses to MDA and age as explanatory variables. The multivariate analysis showed that both IgM responses were strongly associated with NOx levels, age, and IgM responses to MDA. Tests for between-subject effects showed that the IgM responses to NO adducts were associated with NOx levels, while the IgM responses to NO 2 tyrosine were associated with IgM responses to MDA and age. Computed as zAOPP + ZNOx (index of nitro-oxidative stress). AOPP, advanced oxidation protein products; CRP, C-reactive protein; DPSS, depressive and physiosomatic symptoms; FOX, ferrous oxidation xylenol orange; Hp, haptoglobin; Hx MDD, lifetime history of major depression; Hx PMS, lifetime history of premenstrual syndrome; IgM MDA, IgM directed against malondialdehyde; IgM NO, IgM directed against nitroso adducts; NOx, nitric oxide metabolites; TRAP, total radical trapping parameter.
DISCUSSION
The first major finding of this study is that IgM responses to MDA are significantly and inversely associated with AOPP, FOX, and NOx levels. This may indicate a negative feedback of natural IgMmediated autoimmune responses on O&NS processes. MDA is expressed on the surface of oxidized LDL-cholesterol, dying cells, 13 and circulating MP, 14 and may trigger a natural IgM-mediated autoimmune response. 16 This type of natural IgM-mediated regulatory response directed to MDA (and other OSE) plays a key role in clearance of cell debris, dying and apoptotic cells, immune modulation, and tissue homeostasis. 13, 15, 17 IgM antibody responses are highly inducible and upregulation of IgM autoantibody levels is one of the strategies for survival through regulation of inflammatory responses in chronic responses. 51 Therefore, IgM responses to MDA may be part of the compensatory antiinflammatory responses system. 18, 52 The results of the present study suggest that attenuated natural IgM-mediated autoimmune responses during pregnancy are accompanied by lowered regulation and thus increased susceptibility to protein oxidation and elevated NO production. Previously, we found that non-pregnant major depression is accompanied by increased IgM responses to MDA, 30 suggesting that non-pregnant major depression is accompanied by increased natural autoimmune responses, which tend to downregulate the primary immunoinflammatory response.
A large part (71.8%) of the variance in the nitrooxidative stress index was explained by lowered IgM responses to MDA, zinc, and TRAP, coupled with increased inflammatory mediators. This shows that increased nitro-oxidative stress at the end of term is to a large extent determined by the combined effects of attenuated natural autoimmune responses coupled to lowered antioxidant levels and increased inflammatory burden. A recent meta-analysis found increased MDA levels and lowered levels of antioxidants, including zinc and uric acid, in depression, which all improved upon treatment with antidepressant drugs. 53 Zinc is an inhibitor of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, which catalyzes the production of O 2 − from oxygen, resulting in decreased generation of reactive oxygen species. 54 Moreover, zinc is also a co-factor of superoxide dismutase, which catalyzes the dismutation of O 2 − to H 2 O 2 , and binds to sulfhydryl groups of biomolecules protecting them from oxidation. Uric acid provides about 60% of free-radical scavenging capacity in plasma and determines partly TRAP levels. 55 These findings indicate that, at the end of term, lowered antioxidant levels and attenuated natural autoimmune responses play a role in increased protein oxidation and NO production. The second major finding of this study is that IgM responses to MDA are significantly and inversely associated with DPSS, suggesting that autoimmune responses directed against MDA may regulate these symptoms. One mechanistic explanation is that lowered feedback of natural IgM responses increases O&NS and, consequently increases risk to DPSS. Although selective defects in IgM autoimmune responses are not very common, 56 these deficits may be associated with the development of some autoimmune diseases, such as systemic lupus erythematosus (SLE) 57 and rheumatoid arthritis (RA). 58 Patients with SLE generally have lower IgM levels than controls but a higher number of apoptotic cells in the circulation. 51, 59 Decreased IgM levels also occur in various neuropsychiatric disorders, including Alzheimer's disease, deficit schizophrenia, and bipolar disorder. 52, 60, 61 The third major finding of this study is that a history of mood disorders is positively associated with end of term DPSS and IgM responses to NO adducts, whilst the latter negatively impact on DPSS. These findings corroborate previous reports that mood disorders are accompanied by elevated IgM responses to nitrosylated proteins, suggesting that these IgM responses are a trait marker of depression. 16, 30, 62 Nevertheless, the inverse association between IgM responses to NO adducts and DPSS may suggest that these IgM responses are also protective. In physiological conditions, nitrosylation is neuroprotective, 63 whereby nitrosylation plays a critical role in cellular adaptation to increased O&NS. 64 Nitrosylation may act as a defense against the irreversible oxidation of cysteine, which leads to permanent changes in protein structure and function loss. 65 However, excessive O&NS can cause devastating effects through the breakdown of denitrosylation and transnitrosylation mechanisms, which leads to irreversible oxidization of protein thiols, 66 whilst hypernitrosylation may cause neurodegenerative processes. 24, 63 Moreover, some of the IgM responses to NO cysteinyl are neurotoxic and can lead to demyelination and neurodegeneration. 46 Interestingly, DPSS are not only associated with IgM responses to MDA and NO adducts and a history of mood disorders, but also with AOPP levels (positively) and a lifetime history of PMS (positively). In normal pregnancy, there is a significant increase in protein oxidation as indicated by increased AOPP levels, 67 and these oxidative protein products are even higher in those with obstetric complications, such as comorbid gestational diabetes mellitus and pre-eclampsia. 68, 69 PMS is comorbid with other immuno-inflammatory conditions, including major depression, bipolar disorder, as well as perinatal depression. 43, 70 The fourth major finding of this study is that increased NOx levels are associated with IgM responses to NO adducts, but not NO 2 tyrosine, whilst the latter is associated with increased IgM responses to MDA. Different mechanisms may explain why increased NO production is associated with an index of nitrosylation (NO) but not nitration (NO 2 ). Indeed, increased NO production (for which NOx is an index) leads to nitrosylation, whereas nitration is frequently caused by increased peroxynitrite production. Peroxynitrite may cause structural modification of lipids, proteins, and nucleic acids, thereby affecting membrane and mitochondrial functions and DNA integrity. [71] [72] [73] Interestingly, increased NOx production and increased IgM responses to nitrosylated proteins appear to be trait markers for mood disorders. Nevertheless, both MDA and nitro tyrosine are immunogenic neoantigens, which may induce IgM-associated autoimmune processes, explaining the significant correlation between both factors. Interestingly, we found significant associations between increased DPSS scores and a history of alcohol abuse, increased BMI, and anxiety. There is now evidence that women with affective disorders are more likely to suffer from alcohol abuse and dependence and that women with substance abuse experience more depression. 74 There are also known associations between increased incidence or severity of depression and higher BMI and anxiety levels. 5, 75 A limitation of our study is that it was a crosssectional study and thus no causal inferences can be made. It would have been more interesting if we had assayed MDA in order to examine possible associations between MDA formation and increased natural IgM-mediated autoimmune responses to MDA.
Conclusions
Figure 2 summarizes our findings. Pregnancy is associated with lowered zinc and TRAP, increased signs of nitro-oxidative stress (including increased AOPP), hydroperoxides [FOX] , and nitric oxide metabolites [NOx]), and lowered IgM-mediated autoimmune responses to MDA. The latter are natural regulatory responses exerting a negative feedback on increased levels of AOPP, FOX, and NOx. Increased NO production is accompanied by increased nitrosylation of proteins as indicated by higher IgM responses to NO (nitroso) adducts, whilst increased IgM responses to MDA are accompanied by increased IgM responses to nitrotyrosine (NO 2 tyrosine). IgM responses to both MDA and NO adducts may regulate DPSS. Lifetime histories of PMS and mood disorders predict DPSS, while a life history of mood disorders is accompanied by increased NOx production and IgM responses to NO adducts. The latter two indices are therefore possible trait markers of mood disorders. The results of the present study further support the notion that immune activation and increased oxidative and nitrosative stress are new drug targets in depression and perinatal depression and that these disorders could be treated with negative immuno-regulatory and antioxidant compounds. 62 Moreover, the involvement of natural autoimmune responses (which play a role in the resolution of inflammation) in the pathophysiology of perinatal depression may suggest that 'pro-resolving 
